Univest
Univest
  • Markets
  • 3 Branded Medicine Maker, Group Holding Company and Consumerware Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Godrej Industries and Cello World

    • October 19, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Branded Medicine Maker, Group Holding Company and Consumerware Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Godrej Industries and Cello World

    GlaxoSmithKline Pharmaceuticals, Godrej Industries and Cello World compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Vaccine Maker, Surfactant and Pizza Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Galaxy Surfactants and Jubilant FoodWorks

    • October 19, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Vaccine Maker, Surfactant and Pizza Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Galaxy Surfactants and Jubilant FoodWorks

    GlaxoSmithKline Pharmaceuticals, Galaxy Surfactants and Jubilant FoodWorks compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Vaccine Maker, Metal Finishing Chemical and Footwear Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Grauer & Weil (India) and Redtape

    • October 16, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Vaccine Maker, Metal Finishing Chemical and Footwear Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Grauer & Weil (India) and Redtape

    GlaxoSmithKline Pharmaceuticals, Grauer & Weil (India) and Redtape compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Vaccine Maker, Renewable Chemical and Diversified FMCG Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, India Glycols and ITC

    • October 16, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Vaccine Maker, Renewable Chemical and Diversified FMCG Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, India Glycols and ITC

    GlaxoSmithKline Pharmaceuticals, India Glycols and ITC compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Vaccine, Global Generic and Ophthalmology Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Aurobindo Pharma and Dr. Agarwal’s Health Care

    • October 13, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Vaccine, Global Generic and Ophthalmology Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Aurobindo Pharma and Dr. Agarwal's Health Care

    GlaxoSmithKline Pharmaceuticals, Aurobindo Pharma and Dr. Agarwal’s Health Care compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Vaccine, Formulation and Pharmacy Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services

    • October 13, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Vaccine, Formulation and Pharmacy Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services

    GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Trusted Medicine Brand Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Mankind Pharma and FDC

    • October 12, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Trusted Medicine Brand Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Mankind Pharma and FDC

    GlaxoSmithKline Pharmaceuticals, Mankind Pharma and FDC compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more